Search results
Study suggests hypoxia overexpression causes pericytes to contribute to pulmonary hypertension
Medical Xpress· 4 days agoThe overexpression of hypoxia in pericytes contributed to severe pulmonary hypertension (PH) and right ventricular hypertrophy, whereas their removal of ...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Smith Shellnut Wilson LLC ADV
ETF DAILY NEWS· 8 hours agoSmith Shellnut Wilson LLC ADV decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with ...
Letter: Don't take breathing for granted, pass the SOAR Act
New Hampshire Union Leader· 4 days agoTo the Editor: Most of us take breathing for granted, but some people struggle for every breath. In...
The Garabedians: Father and son cardiologists share legacy in the critical care of Spokane's...
The Spokesman-Review· 10 hours agoCarl Garabedian still recalls coming home to Spokane from college to find sickly, lethargic children...
My son needed brain surgery to stop his seizures. Even though I'm his mom, I had a hard time making...
INSIDER via Yahoo News· 6 days agoMy son Trevor didn't have an easy start to life. He was born at 37 weeks because of my high blood...
Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
Medscape· 2 days agoAnti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a...
Johnson & Johnson (NYSE:JNJ) Shares Down 0.3%
ETF DAILY NEWS· 9 hours agoShares of Johnson & Johnson (NYSE:JNJ – Get Free Report) dropped 0.3% during trading on Friday . The company traded as low as $144.48 and last traded at $145.06. Approximately 757,750 shares ...
I worked with terminal patients for decades. This is what they taught me about life
TODAY via Yahoo News· 5 days agoMaybe some simple self-reflection is the key to happiness, writes Dr. David Weill, author and former...
San Diego biotech news: Startup gets funding for drug that tackles overeating
U-T San Diego· 4 days agoLocal biopharmaceutical startup, Aardvark Therapeutics landed $85 million in financing to support...
Tenax Therapeutics, Inc. (NASDAQ:TENX) Short Interest Down 34.7% in May
ETF DAILY NEWS· 3 days agoTenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) was the target of a significant decrease in short interest during the month of May. As of May 31st, there was short interest totalling ...
